Skip to content

A retrospective cohort study of ARDS patients based on a novel classification of hyperinflammatory subphenotypes

A retrospective cohort study of ARDS patients based on a novel classification of hyperinflammatory subphenotypes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115645
Enrollment
Unknown
Registered
2025-12-29
Start date
2025-12-29
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory distress syndrome, ARDS

Interventions

Glucocorticoid treatment group:NA
Dexmedetomidine treatment group:NA

Sponsors

Chongqing Liangjiang New Area People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old; 2. Clearly diagnosed as ARDS (Berlin definition); 3. PaO2/FIO2 = 24 hours.

Exclusion criteria

Exclusion criteria: Severe absence of clinical data (such as lack of baseline data for key biomarkers).

Design outcomes

Primary

MeasureTime frame
The usage time of invasive ventilators;Length of stay in the ICU;28-day mortality rate;60-day mortality rate;Total hospitalization;Prone position ventilation time;The duration of extracorporeal membrane oxygenation treatment;Duration of CRRT;

Secondary

MeasureTime frame
White blood cell count;Proportion of neutrophils;Lymphocyte count;CRP;PCT;IL-6;BNP;D-dimer;TN I;Lung CT;

Countries

China

Contacts

Public ContactXi Chen

Chongqing Liangjiang New Area People's Hospital

mabei0218@126.com+86 159 0931 0787

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026